BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.

Eugenia GkaliagkousiEleni GavriilakiStella BouzianaVarnavas ConstantinouDespina MallouriAnna VardiAnastasia MarvakiIoannis BatsisDamianos SotiropoulosAchilles Anagnostopoulos

Published in: Bone marrow transplantation (2018)

Keyphrases

high dose
acute myeloid leukemia
low dose
hodgkin lymphoma
bone marrow
cell therapy
platelet rich plasma
stem cells
mesenchymal stem cells